| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC0968 |
| Trial ID | ChiCTR2200056396 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B7-H3 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Not Recruiting |
| Title | Prospective clinical study of the safety and efficacy of anti-B7-H3 CAR T cells in the treatment of relapsed, refractory acute myeloid leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||